Clinical Chemistry and Laboratory Medicine (CCLM) · 2023 · 15 citations · 34 references
MedicineChild HealthPediatricsPediatric AllergyPediatric EpidemiologyPediatric ImmunologyAge-period-cohort AnalysisPediatric NeuroimmunologyAge-specific Reference RangesNeurological Disease BiomarkersPediatric Allergy TestingPediatric BiomarkersQuantile RegressionReference Interval DeterminationReference Interval EstablishmentReference Interval Verification
OBJECTIVES: Glial fibrillary acidic protein (GFAP) in blood is an emerging biomarker of brain injury and neurological disease. Its clinical use in children is limited by the lack of a reference interval (RI). Thus, the aim of the present study was to establish an age-dependent continuous RI for serum GFAP in children. METHODS: Excess serum from routine allergy testing of 391 children, 0.4-17.9 years of age, was measured by a single-molecule array (Simoa) assay. A continuous RI was modelled using non-parametric quantile regression and presented both graphically and tabulated as discrete one-year RIs based on point estimates from the model. RESULTS: Serum GFAP showed a strong age-dependency with declining levels and variability from infants to adolescents. The estimated median level decreased 66 % from four months to five years of age and another 65 % from five years to 17.9 years of age. No gender difference was observed. CONCLUSIONS: The study establishes an age-dependent RI for serum GFAP in children showing high levels and variability in the first years of life.
34
Quantitative growth and development of human brain
John Dobbing, Jean Sands · Archives of Disease in Childhood · 1973 · 1.5K citations · Full text
Linda Papa, Gretchen M. Brophy, Robert D. Welch et al. · JAMA Neurology · 2016 · 514 citations · Full text
Medicine, Neurology, Neuroscience +14
Constructing time‐specific reference ranges
Patrick Royston · Statistics in Medicine · 1991 · 311 citations